Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case–control study
Authors:
- 1 June 2003
- journal article
- website
- Published by Wiley in Transplant Infectious Disease
- Vol. 5 (2) , 84-93
Abstract
Objective. To analyze risk factors for Pneumocystis carinii pneumonia (PCP) in kidney transplant recipients.Study design. In a case–control study, 17 PCP cases diagnosed between July 1994 and July 2000 were matched with two controls each (previous and subsequent kidney transplant recipients who did not develop PCP during the same follow‐up period). Demographics, organ origin, human leukocyte antigen (HLA) mismatches, use of poly‐ or monoclonal anti‐CD3 antibodies (Po/MoAb) for induction or rejection treatment, rejection episodes, cumulative steroid dose for rejection treatment, immunosuppressive regimens, and other infections were analyzed.Results. No significant differences were seen in gender (male 10 vs. 15), mean age (39.7 vs. 35.4 years), organ origin (cadaver donor 13 vs. 19), HLA mismatches, or Po/MoAb use in induction treatment. Significant differences were observed in PCP cases for rejection history (P=0.02), and median and total number of rejection episodes (P=0.0018). The relative risks for PCP for 1, 2, and ≥3 rejection treatments vs. no such treatment were 1, 1.05, and 6.30, respectively (P=0.021). The relative risk for PCP for steroid‐resistant rejection was 4.34 (95% confidence interval [CI], 1.04–18.89) (P=0.019), and that for the use of Po/MoAb for rejection treatment was 7.23 (95% CI, 1.28–49.34) (P=0.006). The relative risk for PCP for 0, 1, and ≥2 previous or concomitant cytomegalovirus (CMV) infection vs. no such infections were 1.0, 2.32, and 13.0, respectively (P=0.012). The relative risks for PCP for tuberculosis (TB) was 18 (95% CI, 1.76–852.03), that for bacterial pneumonia was 14.22 (95% CI, 2.16–150.23), and that for hepatitis C virus infection was 5.25 (95% CI, 1.03–28.91). Immunosuppressive regimens with tacrolimus, mycophenolate mofetil (MMF), steroids (P=0.06), and MMF as a single variable (P=0.05) were more frequently used in cases. Primary trimethoprim‐sulfamethoxazole prophylaxis failure was observed in 12 patients in association with heavy immunosuppression and concomitant infections.Conclusions. The risk of PCP in kidney transplant recipients is related to the number and type of rejection treatments. It is also related to the occurrence of CMV infection, and to other immunomodulating infections such as TB and hepatitis C, and might also be increased with the use of newer and more potent immunosuppressive agents. Primary prophylaxis failure may occur in association with some of these risk factors.Keywords
This publication has 20 references indexed in Scilit:
- Ineffectiveness of Trimethoprim‐Sulfamethoxazole Prophylaxis and the Importance of Bacterial and Viral Coinfections in African Children withPneumocystis cariniiPneumoniaClinical Infectious Diseases, 2002
- Prophylaxis Failure Is Associated with a SpecificPneumocystis cariniiGenotypeClinical Infectious Diseases, 2001
- Dual Pulmonary Infection with Mycobacterium tuberculosis and Pneumocystis carinii in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 2001
- Should Prophylaxis for Pneumocystis carinii Pneumonia in Solid Organ Transplant Recipients Ever Be Discontinued?Clinical Infectious Diseases, 1999
- NovelAnti‐Pneumocystis cariniiEffects of the Immunosuppressant Mycophenolate Mofetil in Contrast to Provocative Effects of Tacrolimu Sirolimus, and DexamethasoneThe Journal of Infectious Diseases, 1997
- INCIDENCE OF Pneumocystis carinii PNEUMONIA AFTER RENAL TRANSPLANTATIONTransplantation, 1996
- Rejection Treatment and Cytomegalovirus Infection as Risk Factors for Pneumocystis carinii Pneumonia in Renal Transplant RecipientsClinical Infectious Diseases, 1996
- Normalization of CD4+ T-Lymphocyte Depletion in Patients Without HIV Infection Treated for TuberculosisChest, 1994
- Characteristics of Immunosuppressive Macrophages Induced in Host Spleen Cells by Mycobacterium avium Complex and Mycobacterium tuberculosis Infections in MiceMicrobiology and Immunology, 1990
- THE RISKS AND BENEFITS OF LOW-DOSE COTRIMOXAZOLE PROPHYLAXIS FOR PNEUMOCYSTIS PNEUMONIA IN RENAL TRANSPLANTATIONTransplantation, 1989